China's CH-7 high-altitude, high-speed drone conducts its maiden flight in a northwestern province. [Photo provided to chinadaily.com.cn] China's CH-7 high-altitude, high-speed drone recently ...
Natera, Inc. (NASDAQ:NTRA) stands sixth on our list among the most promising stocks. TheFly reported on December 15 that J.P. Morgan raised its price target on NTRA from $250 to $260 while maintaining ...
China's CH-7 stealth unmanned aerial vehicle has undergone multiple design changes and tweaks over the last eight years to resolve stability- and performance-related issues. (Janes/China Central ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. I think we can all agree that 2025 has been a year of events and occurrences. Sure, many of those ...
GameSpot may get a commission from retail offers. A leading industry observer has predicted that EA's Battlefield 6 is "extremely likely" to outsell Activision's Call of Duty: Black Ops 7 in the US to ...
(WASHINGTON) -- The federal government released two major economic reports this week, easing a backlog of data pent up by the 43-day government shutdown. The data flashed some warning signs, showing ...
Bitcoin’s price structure signal has turned negative and the Bull‑Bear Index shows fading spot demand and rising derivatives pressure, putting BTC in a risk‑off, bear‑leaning regime until signals ...
China continues to modernize its air power, with a stealth unmanned aerial vehicle, also known as a drone, conducting its first flight, footage released on Monday shows. "Follow-on tests are expected ...
On December 9, Stifel reaffirmed its ‘Buy’ rating on OneSpaWorld Holdings Limited (NASDAQ:OSW) with a price target of $27, which suggests an upside potential of about 32%. This optimism follows ...
Continuing a recent trend of announcing significant developments in military aviation around the end-of-year, China has revealed the first flight of another experimental uncrewed jet. This time it is ...
Even after the VIK stock rallied from about $57.50 to $68.75, Jefferies sees more upside ahead. After plummeting from about $67.50 to $43.85 on healthcare policy uncertainty, Morgan Stanley upgraded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback